• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒进化过程中 SARS-CoV-2 受体结合域突变约束的转变。

Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution.

机构信息

Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Department of Genome Sciences, University of Washington, Seattle, WA 98109, USA.

出版信息

Science. 2022 Jul 22;377(6604):420-424. doi: 10.1126/science.abo7896. Epub 2022 Jun 28.

DOI:10.1126/science.abo7896
PMID:35762884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9273037/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved variants with substitutions in the spike receptor-binding domain (RBD) that affect its affinity for angiotensin-converting enzyme 2 (ACE2) receptor and recognition by antibodies. These substitutions could also shape future evolution by modulating the effects of mutations at other sites-a phenomenon called epistasis. To investigate this possibility, we performed deep mutational scans to measure the effects on ACE2 binding of all single-amino acid mutations in the Wuhan-Hu-1, Alpha, Beta, Delta, and Eta variant RBDs. Some substitutions, most prominently Asn→Tyr (N501Y), cause epistatic shifts in the effects of mutations at other sites. These epistatic shifts shape subsequent evolutionary change-for example, enabling many of the antibody-escape substitutions in the Omicron RBD. These epistatic shifts occur despite high conservation of the overall RBD structure. Our data shed light on RBD sequence-function relationships and facilitate interpretation of ongoing SARS-CoV-2 evolution.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)已经进化出具有刺突受体结合域(RBD)取代的变体,这些取代会影响其与血管紧张素转换酶 2(ACE2)受体的亲和力和抗体的识别。这些取代也可能通过调节其他位点突变的影响来塑造未来的进化——这一现象称为上位性。为了研究这种可能性,我们进行了深度突变扫描,以测量武汉株、阿尔法、贝塔、德尔塔和伊塔变体 RBD 中所有单一氨基酸突变对 ACE2 结合的影响。一些取代,最明显的是天冬酰胺→酪氨酸(N501Y),导致其他位点突变的影响发生上位性转变。这些上位性转变塑造了随后的进化变化——例如,使奥密克戎 RBD 中的许多抗体逃逸取代成为可能。尽管 RBD 整体结构高度保守,但这些上位性转变仍在发生。我们的数据阐明了 RBD 序列-功能关系,并有助于解释正在进行的 SARS-CoV-2 进化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/4fd0d2c3c922/science.abo7896-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/b3490267ae3a/science.abo7896-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/184f4fefef70/science.abo7896-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/718cd0115380/science.abo7896-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/4fd0d2c3c922/science.abo7896-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/b3490267ae3a/science.abo7896-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/184f4fefef70/science.abo7896-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/718cd0115380/science.abo7896-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9273037/4fd0d2c3c922/science.abo7896-f4.jpg

相似文献

1
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution.病毒进化过程中 SARS-CoV-2 受体结合域突变约束的转变。
Science. 2022 Jul 22;377(6604):420-424. doi: 10.1126/science.abo7896. Epub 2022 Jun 28.
2
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.SARS-CoV-2 变体预测和抗病毒药物设计可通过 RBD 体外进化实现。
Nat Microbiol. 2021 Sep;6(9):1188-1198. doi: 10.1038/s41564-021-00954-4. Epub 2021 Aug 16.
3
Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains.在 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 受体结合域中进行 ACE2 结合、RBD 表达和抗体逃逸的深度突变扫描。
PLoS Pathog. 2022 Nov 18;18(11):e1010951. doi: 10.1371/journal.ppat.1010951. eCollection 2022 Nov.
4
Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.SARS-CoV-2 受体结合域界面的上位性作用及对疫苗逃逸的有利影响
mBio. 2022 Apr 26;13(2):e0013522. doi: 10.1128/mbio.00135-22. Epub 2022 Mar 15.
5
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.AlphaFold2 对 SARS-CoV-2 刺突奥密克戎 JN.1、KP.2 和 KP.3 变体构象集合的建模和分子动力学模拟:结合能突变分析揭示 ACE2 亲和力的上位驱动因素和抗体耐药性逃逸热点。
Viruses. 2024 Sep 13;16(9):1458. doi: 10.3390/v16091458.
6
Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape.基于集成的SARS-CoV-2刺突奥密克戎XBB谱系与ACE2受体及抗体相互作用的突变分析和网络分析:结合热点在介导上位性偶联中的协同作用是结合机制和免疫逃逸的基础
Int J Mol Sci. 2024 Apr 12;25(8):4281. doi: 10.3390/ijms25084281.
7
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.常见突变对 SARS-CoV-2 刺突 RBD 及其配体人 ACE2 受体结合亲和力和动力学的影响。
Elife. 2021 Aug 26;10:e70658. doi: 10.7554/eLife.70658.
8
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
9
Deep mutational scans of XBB.1.5 and BQ.1.1 reveal ongoing epistatic drift during SARS-CoV-2 evolution.深度突变扫描显示,XBB.1.5 和 BQ.1.1 期间 SARS-CoV-2 进化持续发生上位性漂移。
PLoS Pathog. 2023 Dec 29;19(12):e1011901. doi: 10.1371/journal.ppat.1011901. eCollection 2023 Dec.
10
Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.人类受体识别 SARS-CoV-2 奥密克戎变异株 BA.1 的结构基础
J Virol. 2022 Apr 27;96(8):e0024922. doi: 10.1128/jvi.00249-22. Epub 2022 Mar 28.

引用本文的文献

1
Heterogeneous Evolution Among SARS-CoV-2 Genes and Variants of Concern.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因与关注变异株之间的异质性进化
J Med Virol. 2025 Sep;97(9):e70604. doi: 10.1002/jmv.70604.
2
Determinants of human versus mosquito cell entry by the Chikungunya virus envelope proteins.基孔肯雅病毒包膜蛋白进入人类细胞与蚊子细胞的决定因素。
bioRxiv. 2025 Aug 25:2025.08.25.672233. doi: 10.1101/2025.08.25.672233.
3
Structural and functional analysis of VYD222: a broadly neutralizing antibody against SARS-CoV-2 variants.VYD222的结构与功能分析:一种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的广谱中和抗体

本文引用的文献

1
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail.SARS-CoV-2 刺突 E406W 突变体逃避临床单克隆抗体鸡尾酒的结构变化。
Cell Rep. 2023 Jun 27;42(6):112621. doi: 10.1016/j.celrep.2023.112621. Epub 2023 May 26.
2
In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding.体外进化预测了具有高亲和力结合 ACE2 和跨物种结合的 SARS-CoV-2 新出现突变。
PLoS Pathog. 2022 Jul 18;18(7):e1010733. doi: 10.1371/journal.ppat.1010733. eCollection 2022 Jul.
3
An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain.
bioRxiv. 2025 Aug 28:2025.08.28.672883. doi: 10.1101/2025.08.28.672883.
4
Spike mutations that affect the function and antigenicity of recent KP.3.1.1-like SARS-CoV-2 variants.影响近期类似KP.3.1.1的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体功能和抗原性的刺突突变。
bioRxiv. 2025 Aug 19:2025.08.18.671001. doi: 10.1101/2025.08.18.671001.
5
Bivalent mRNA booster encoding virus-like particles elicits potent polyclass RBD antibodies in pre-vaccinated mice.编码病毒样颗粒的二价mRNA加强针在预先接种疫苗的小鼠中引发强效多类RBD抗体。
bioRxiv. 2025 Aug 19:2025.08.18.670983. doi: 10.1101/2025.08.18.670983.
6
Widespread epistasis shapes RNA polymerase II active site function and evolution.广泛的上位性塑造了RNA聚合酶II活性位点的功能和进化。
Nat Commun. 2025 Aug 27;16(1):7993. doi: 10.1038/s41467-025-63304-6.
7
design of immunogenic antigen cocktail via affinity maturation-guided optimization.通过亲和力成熟引导优化设计免疫原性抗原鸡尾酒。
Bioinform Adv. 2025 Jul 28;5(1):vbaf182. doi: 10.1093/bioadv/vbaf182. eCollection 2025.
8
A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron.单个突变可能有助于新冠病毒向奥密克戎毒株加速进化。
Nat Commun. 2025 Jul 29;16(1):6951. doi: 10.1038/s41467-025-62300-0.
9
Single administration of mosaic-8b RBD-nanoparticle vaccine prepared with atomic layer deposition technology elicits broadly neutralizing anti-sarbecovirus responses.单次接种采用原子层沉积技术制备的嵌合-8b受体结合域纳米颗粒疫苗可引发广泛中和抗沙贝病毒反应。
bioRxiv. 2025 Jun 18:2025.06.16.660007. doi: 10.1101/2025.06.16.660007.
10
CATH-ddG: towards robust mutation effect prediction on protein-protein interactions out of CATH homologous superfamily.CATH-ddG:用于对CATH同源超家族之外的蛋白质-蛋白质相互作用进行可靠的突变效应预测。
Bioinformatics. 2025 Jul 1;41(Supplement_1):i362-i372. doi: 10.1093/bioinformatics/btaf228.
一种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域突变的抗体逃逸估计器。
Virus Evol. 2022 May 11;8(1):veac021. doi: 10.1093/ve/veac021. eCollection 2022.
4
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage.全球 SARS-CoV-2 C.1.2 谱系的出现和表型特征。
Nat Commun. 2022 Apr 8;13(1):1976. doi: 10.1038/s41467-022-29579-9.
5
Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein.在法国南部出现了一种新的 SARS-CoV-2 变异株,其刺突蛋白中同时携带 N501Y 和 E484K 突变。
Arch Virol. 2022 Apr;167(4):1185-1190. doi: 10.1007/s00705-022-05385-y. Epub 2022 Feb 18.
6
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy.一种 SARS-CoV-2 变体引起了抗体反应,免疫优势等级发生了转移。
PLoS Pathog. 2022 Feb 8;18(2):e1010248. doi: 10.1371/journal.ppat.1010248. eCollection 2022 Feb.
7
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses.ACE2 结合是沙贝病毒科的一个祖传且可进化的特征。
Nature. 2022 Mar;603(7903):913-918. doi: 10.1038/s41586-022-04464-z. Epub 2022 Feb 3.
8
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.新冠病毒奥密克戎改变 TMPRSS2 的使用方式影响其感染性和融合性。
Nature. 2022 Mar;603(7902):706-714. doi: 10.1038/s41586-022-04474-x. Epub 2022 Feb 1.
9
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2.人血管紧张素转化酶 2 与奥密克戎和德尔塔 SARS-CoV-2 刺突 RBD 的受体结合和复合物结构。
Cell. 2022 Feb 17;185(4):630-640.e10. doi: 10.1016/j.cell.2022.01.001. Epub 2022 Jan 6.
10
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.SARS-CoV-2 奥密克戎免疫逃逸和受体结合的结构基础。
Science. 2022 Feb 25;375(6583):864-868. doi: 10.1126/science.abn8652. Epub 2022 Jan 25.